New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the Aplastic Anemia market is poised for strong expansion and is expected to reach USD 10,029.32 Million by 2030. The market, which was valued at USD 6,742.48 Million in 2022, is predicted to grow at a compound annual growth rate of 5.1% during the period 2023-2030. The report highlights the increasing adoption of aplastic anemia treatment in hospitals, which is accelerating the market growth at the global level. Reports Insights study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the aplastic anemia market. Request Sample Now
The aplastic anemia treatment is an ideal solution for hospitals to enable a reduction in bleeding, infection, and others. The aplastic anemia treatment increases the bone marrow to increase new blood cells. In addition, the favorable programs for increasing the adoption of aplastic anemia treatment in hospitals are boosting the growth of the global aplastic anemia treatment market.
Furthermore, the increasing pipelines for aplastic anemia with a focus on minimizing the impact and spread of aplastic anemia will boost the commercialization and expansion of product offerings in the global aplastic anemia market. For instance, Hemogenyx Pharmaceuticals plc is developing Hu-PHEC Liver to treat aplastic anemia. Therefore, the recent pipelines for aplastic anemias will create a favorable growth outlook for the aplastic anemia market.
Apply For Free Sample Report@ https://www.reportsinsights.com/sample/673899
Global Aplastic Anemia Market Segmentation Details:
Based on Treatment Type, the drug therapy segment contributed the highest market share in 2022. Drug therapies are efficient for the treatment of aplastic anemia to minimize morbidity and help prevent complications such as infections, heart problems, and bleeding, among others. Drug therapies, including cyclosporine (Neoral, Gengraf, and Sandimmune), anti-thymocyte globulin, and others are frequently used in the treatment of aplastic anemia. Thus, the above benefits associated with drug therapies are spurring the growth of the segment.
Based on End User, the hospital segment is anticipated to offer substantial shares in the global Aplastic Anemia market. In hospitals, various aplastic anemia treatments are employed to suppress the activity of immune cells, which may pose damage the patient's bone marrow. This helps the bone marrow to recover and produce new blood cells. Furthermore, the development of new hospital facilities for the treatment of aplastic anemia is fostering the growth of the market.
Based on region, in the year 2022, North America accounted for the largest share contribution to the market growth. The prime factors, including the increasing research & development activities associated with the aplastic anemia drug discovery, strategic partnerships, and others are accelerating the growth of the aplastic anemia market in the North American region.
Aplastic Anemia Market Research Coverage :-
| Report Attributes | Report Details |
| Market Size By 2030 | USD 10,029.32 Million |
| Forecast Period | 2023-2030 |
| CAGR (2023-2030) | 5.1% |
| Base Year | 2022 |
| Study Timeline | 2017-2030 |
| Key Players | Novartis Pharmaceuticals Corporation, Kyowa Kirin Co., Ltd., Foresee Pharmaceuticals, Cellenkos, Hemogenyx, Gamida Cell Ltd., GlaxoSmithKline Plc, Eisai Co. Ltd., Amyndas Pharmaceuticals S.A., and AbbVie Inc. |
| By Treatment Type | Bone Marrow Transfusion/Stem Cell Therapy Blood Transfusion Drug Therapy |
| By End User | Hospitals Research Institutes Others |
| Report Coverage | Company Ranking and Market Share, Growth Factors, Total Revenue Forecast, Regional Competitive Landscape, Business Strategies, and more. |
| By Geography | North America, Asia-Pacific, Latin America, Europe, Middle East & Africa |
Browse Full Report with Table of Content (TOC) @ https://www.reportsinsights.com/industry-forecast/global-aplastic-anemia-market-statistical-analysis-673899
Key Market Takeaways
- North America will create favorable circumstances for market growth in terms of value due to the growing development of new methods for the treatment of aplastic anemia particularly in countries such as the United States, Canada, and others.
- Based on treatment type, the drug therapy segment accounted for the highest share contribution to the aplastic anemia market statistics in 2022.
- In the context of end user, the hospital segment is expected to contribute significant shares to the growth of aplastic anemia market statistics during the forecast period.
Competitive Landscape
Novartis Pharmaceuticals Corporation, Kyowa Kirin Co., Ltd., and Foresee Pharmaceuticals, among others, are major market players that comprise the latest market circumstances. These companies have strong production capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. Further, the aplastic anemia market is expected to grow at a substantial rate due to rising demand for treatment of aplastic anemia especially in the Asia Pacific, North America, and Europe regions which are estimated to boost the market statistics in the coming years. Additionally, the strategic collaborations for the development of a new range of aplastic anemia medications will further increase the competition in the market.
Request for Inquiry or Customization Request @ https://www.reportsinsights.com/enquiry/673899
Recent Developments
- In August 2021, GSK Plc, a leading manufacturer of pharmaceuticals in the United Kingdom, received FDA approval for JEMPERLI (dostarlimab-gxly). This drug can be utilized for the treatment of aplastic anemia.
List of Major Global Aplastic Anemia Market:
- Novartis Pharmaceuticals Corporation
- Kyowa Kirin Co., Ltd.
- Foresee Pharmaceuticals
- Cellenkos, Hemogenyx
- Gamida Cell Ltd.
- GlaxoSmithKline Plc
- Eisai Co. Ltd.
- Amyndas Pharmaceuticals S.A.
- AbbVie Inc.
Global Aplastic Anemia Market Segmentation:
- By Treatment Type
- Bone Marrow Transfusion/Stem Cell Therapy
- Blood Transfusion
- Drug Therapy
- By End User
- Hospitals
- Research Institutes
- Others
Frequently Asked Questions in the Aplastic Anemia Market Report
What was the market size of the aplastic anemia industry in 2020?
What will be the potential market valuation for the aplastic anemia industry by 2030?
What are the key factors driving the growth of the aplastic anemia market, as well as the opportunities that may impact the market’s future development?
What is the dominating segment in the aplastic anemia market by treatment type?
Based on current market trends and future predictions, which geographical region will have the fastest impact on the aplastic anemia market's growth in the coming years?
Discover More With Reports Insights Library Of Others Research Reports:-
Iron Deficiency Anemia Therapy Market Size, Growth, By Regions (North America, Europe, Asia Pacific, South America, Middle East And Africa), Analysis, Industry Trends and Forecast (2022-2028)
Anemia Therapeutics Market Analysis By Regions (North America, Europe, Asia Pacific, South America, Middle East And Africa), Size, Growth, Trend and Forecast with Impact Analysis of COVID-19 (2022-2028)
Anemia Treatment Drugs Market Analysis By Regions (North America, Europe, Asia Pacific, South America, Middle East And Africa), Size, Growth, Trend and Forecast with Impact Analysis of COVID-19 (2022-2028)
Sickle Cell Anemia Drug Market Analysis By Regions (Europe, North America, Asia Pacific, South America, Middle East And Africa), Growth, Trends and Forecast with Impact Analysis of COVID-19 (2022-2028)
Freeze Drying Equipment Market Size, Share & Trends Analysis, By Product (Bench Top Freeze Dryers, Laboratory Freeze Dryers, Mobile Freeze Dryers, General Purpose Freeze Dryers, Industrial Freeze Dryers, Others), By Application (Biotechnolog, Pharmaceuticals, Food Processing, Surgical Procedures, Others), By Region and Segments, Growth, Forecast Period 2022 - 2030
Drug Discovery Informatics Market Size, Share & Trends Analysis, By Type (Software, Services (Sequence and Target Data Analysis Platforms, Libraries and Database Preparation, Docking, Molecular Modeling, and Others), Workflows (Discovery Informatics (Lead Generation Informatics, Identification & Validation Informatics, Assay Development Informatics) Development Informatics (FHD Preparation, Lead Optimization, Phase IA Informatics, Phase IB /2 Informatics), Mode (In-House Informatics, Outsourced Informatics), End Use (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), and Others), By Region and Segment, Forecast Period 2023 - 2030
About Reports Insights Consulting Pvt Ltd
ReportsInsights Consulting Pvt Ltd. is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domains. The industry provides consulting services, syndicated research reports, and customized research reports.
Topnotch research organizations and institutions to comprehend the regional and global commercial status use the data produced by ReportsInsights Consulting Pvt Ltd. Our reports comprise in-depth analytical and statistical analysis on various industries in the foremost countries around the globe.
Contact:
Email: sales@reportsinsights.com
USA: +1-214-272-0393
Europe: +44-20-8133-9198
Website:- https://www.reportsinsights.com
